Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Resmed Inc (RMD)

Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 34,830,288
  • Shares Outstanding, K 146,796
  • Annual Sales, $ 4,685 M
  • Annual Income, $ 1,021 M
  • EBIT $ 1,464 M
  • EBITDA $ 1,680 M
  • 60-Month Beta 0.68
  • Price/Sales 7.26
  • Price/Cash Flow 25.10
  • Price/Book 6.54

Options Overview Details

View History
  • Implied Volatility 34.97% ( -2.57%)
  • Historical Volatility 28.78%
  • IV Percentile 59%
  • IV Rank 31.48%
  • IV High 63.20% on 08/01/24
  • IV Low 22.00% on 05/09/24
  • Put/Call Vol Ratio 6.80
  • Today's Volume 2,690
  • Volume Avg (30-Day) 668
  • Put/Call OI Ratio 3.46
  • Today's Open Interest 32,710
  • Open Int (30-Day) 29,884

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 2.29
  • Number of Estimates 4
  • High Estimate 2.33
  • Low Estimate 2.25
  • Prior Year 1.88
  • Growth Rate Est. (year over year) +21.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
229.94 +3.19%
on 12/18/24
252.36 -5.98%
on 11/29/24
-4.28 (-1.77%)
since 11/20/24
3-Month
229.94 +3.19%
on 12/18/24
260.49 -8.91%
on 10/25/24
-7.67 (-3.13%)
since 09/20/24
52-Week
164.12 +44.57%
on 01/04/24
260.49 -8.91%
on 10/25/24
+63.30 (+36.39%)
since 12/20/23

Most Recent Stories

More News
Is ResMed Stock Outperforming the Nasdaq?

ResMed has outpaced the broader Nasdaq Composite index over the past year, and Wall Street analysts are moderately bullish about the stock’s prospects.

$NASX : 19,572.60 (+1.03%)
BSX : 88.95 (+0.33%)
RMD : 237.27 (+2.46%)
How Is West Pharmaceutical Services' Stock Performance Compared to Other Medical Devices Stocks?

West Pharmaceutical Services has underperformed other medical devices stocks over the past year, yet analysts remain bullish on the stock’s prospects.

RMD : 237.27 (+2.46%)
WST : 331.40 (+1.34%)
MDEV : 20.76 (+1.16%)
Insider Sale: Chief Financial Officer of $RMD (RMD) Sells 1,000 Shares

Brett Sandercock, the Chief Financial Officer of $RMD ($RMD), sold 1,000 shares of the company on 12-09-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.1%...

RMD : 237.27 (+2.46%)
Cooper Companies Q4 Earnings Beat, Revenues Miss, Stock Falls

The Cooper Companies, Inc. COO delivered fourth-quarter fiscal 2024 adjusted earnings per share (EPS) of $1.04, which improved 19.5% year over year. The figure surpassed the Zacks Consensus Estimate by...

COO : 93.44 (+1.64%)
GMED : 82.63 (+0.84%)
RMD : 237.27 (+2.46%)
CAH : 118.28 (+1.09%)
Insider Sale: Director at $RMD (RMD) Sells 2,000 Shares

PETER C FARRELL, a director at $RMD ($RMD), sold 2,000 shares of the company on 12-04-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.4% of their shares....

RMD : 237.27 (+2.46%)
Insider Sale: Global General Counsel of $RMD (RMD) Sells 74 Shares

Michael J Rider, the Global General Counsel of $RMD ($RMD), sold 74 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.8% of...

RMD : 237.27 (+2.46%)
Insider Sale: Chief Product Officer of $RMD (RMD) Sells 6,160 Shares

Justin Leong, the Chief Product Officer of $RMD ($RMD), sold 6,160 shares of the company on 11-22-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 22.1% of...

RMD : 237.27 (+2.46%)
ResMed Stock: Is Wall Street Bullish or Bearish?

Although ResMed has outperformed relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

XLV : 138.00 (+1.26%)
$SPX : 5,930.85 (+1.09%)
RMD : 237.27 (+2.46%)
Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours

Alcon, Inc. ALC delivered core earnings per share (EPS) of 81 cents for the third quarter of 2024, up 22.7% from the year-ago quarter’s figure (up 25% at the constant exchange rate or CER). The figure...

DGX : 153.10 (+1.04%)
BSX : 88.95 (+0.33%)
RMD : 237.27 (+2.46%)
ALC : 84.76 (+0.69%)
Exploring the $188 Billion Opportunity: Why AI is Set to Transform Global Healthcare by 2030

/CNW/ -- Recently the World Economic Forum released a report that highlights AI's potential to relieve pressure on healthcare systems worldwide, with Mayo...

MSFT : 436.60 (-0.10%)
AIDX.TO : 2.00 (-2.91%)
HWAIF : 1.4000 (-1.41%)
NVDA : 134.70 (+3.08%)
AVAI : 0.5600 (+1.80%)
WELL.TO : 7.10 (+1.14%)
RMD.AX : 36.810 (-0.32%)
RMD : 237.27 (+2.46%)
WHTCF : 4.9800 (+1.32%)
CLOV : 3.23 (+1.25%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory...

See More

Key Turning Points

3rd Resistance Point 247.85
2nd Resistance Point 243.22
1st Resistance Point 240.25
Last Price 237.27
1st Support Level 232.65
2nd Support Level 228.02
3rd Support Level 225.05

See More

52-Week High 260.49
Last Price 237.27
Fibonacci 61.8% 223.68
Fibonacci 50% 212.31
Fibonacci 38.2% 200.93
52-Week Low 164.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar